Cardiol Therapeutics Inc. Income Tax Expense Continuing Operations
Cardiol Therapeutics Inc. (CRDL) reported Income Tax Expense Continuing Operations of CAD 0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-29.
Discontinued › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2023-03-29
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2022-12-31 | 0.00 CAD 20-F · filed 2023-03-29 |
| 2021-12-31 | 0.00 CAD 20-F · filed 2023-03-29 |
| 2020-12-31 | 0.00 CAD 20-F · filed 2023-03-29 |